Taenia is a genus of tapeworms. Intestinal infection with an adult tapeworm is called taeniasis. Cysticercosis is a different condition involving larval tissue infection from Taenia solium eggs. These terms should not be treated as interchangeable.
On this page
Why species and route of exposure matter
Intestinal taeniasis can follow eating undercooked meat containing larval stages. Cysticercosis follows ingestion of T. solium eggs, which can contaminate food, water or hands. Eating pork and developing tissue cysts are not the same biological pathway. [1]
What GI-MAP reports
The report includes a Taenia group target. A detected result does not necessarily distinguish T. solium from T. saginata or other covered species. It also does not image tissue or diagnose neurocysticercosis in the brain. Ask the laboratory about exact target coverage if species identification is needed. [2]
How a clinician may clarify the finding
Clinical investigation can include stool examination and identification of eggs or tapeworm segments. Taenia eggs alone may not distinguish species, making other identifying information important. A DNA result, microscopy and segment identification are different forms of evidence. [3]
Bring any history of passing segments, relevant travel and possible food exposure. Do not handle or submit material without the laboratory’s collection instructions.
What negative and positive stool results cannot settle
A negative stool panel does not exclude tissue cysticercosis. A positive Taenia target does not prove it. New seizures, severe neurological symptoms or other acute concerns need urgent medical assessment independent of the stool result. A clinician should select treatment after considering the actual diagnosis.
Common questions
Does Taenia detected mean a brain infection?
No. Intestinal tapeworm detection and neurocysticercosis are different questions requiring different investigations.
Can GI-MAP count the number of tapeworms?
No. The target result is not a direct adult-worm count or a measure of tissue burden.
Sources and review
Sources checked October 7, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- WHO: Taeniasis and cysticercosis
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
- CDC DPDx: Taeniasis
Medical review of this article is pending. For a correction or source question, contact GI MAP Test.